PortfoliosLab logo

Luye Pharma Group Ltd (2186.HK)

Equity · Currency in HKD · Last updated May 27, 2023

Company Info

ISINBMG570071099
SectorHealthcare
IndustryDrug Manufacturers—General

Highlights

Market CapHK$12.98B
EPSHK$0.02
PE Ratio18.16
PEG RatioN/A
Revenue (TTM)HK$5.98B
Gross Profit (TTM)HK$3.40B
EBITDA (TTM)HK$1.43B
Year RangeHK$1.88 - HK$4.65
Target PriceHK$4.09

Share Price Chart


Loading data...

Performance

The chart shows the growth of an initial investment of HK$10,000 in Luye Pharma Group Ltd, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-50.00%0.00%50.00%100.00%December2023FebruaryMarchAprilMay
-44.69%
115.14%
2186.HK (Luye Pharma Group Ltd)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with 2186.HK

Luye Pharma Group Ltd

Return

Luye Pharma Group Ltd had a return of -5.74% year-to-date (YTD) and 44.35% in the last 12 months. Over the past 10 years, Luye Pharma Group Ltd had an annualized return of -6.61%, while the S&P 500 had an annualized return of 9.24%, indicating that Luye Pharma Group Ltd did not perform as well as the benchmark.


PeriodReturnBenchmark
1 month-10.39%-0.59%
Year-To-Date-5.74%7.47%
6 months14.62%2.91%
1 year44.35%-4.20%
5 years (annualized)-16.42%8.70%
10 years (annualized)-6.61%9.24%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
20239.84%-10.20%0.83%5.77%
2022-12.39%59.16%20.39%

Risk-Adjusted Performance

This table presents a comparison of risk-adjusted performance metrics for Luye Pharma Group Ltd (2186.HK) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
2186.HK
Luye Pharma Group Ltd
1.02
^GSPC
S&P 500
0.27

Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Luye Pharma Group Ltd Sharpe ratio is 1.02. A Sharpe ratio greater than 1.0 is considered acceptable.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.500.000.501.001.50December2023FebruaryMarchAprilMay
1.02
0.07
2186.HK (Luye Pharma Group Ltd)
Benchmark (^GSPC)

Dividend History

Luye Pharma Group Ltd granted a 0.00% dividend yield in the last twelve months. The annual payout for that period amounted to HK$0.00 per share.


PeriodTTM2022202120202019201820172016
DividendHK$0.00HK$0.00HK$0.00HK$0.06HK$0.13HK$0.11HK$0.07HK$0.04

Dividend yield

0.00%0.00%0.00%1.66%2.29%1.99%1.22%0.86%

Monthly Dividends

The table displays the monthly dividend distributions for Luye Pharma Group Ltd. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDec
2023HK$0.00HK$0.00HK$0.00HK$0.00
2022HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2021HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2020HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.06HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00
2019HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.07HK$0.00HK$0.00HK$0.07HK$0.00HK$0.00HK$0.00
2018HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.05HK$0.00HK$0.00HK$0.05HK$0.00HK$0.00HK$0.00
2017HK$0.00HK$0.00HK$0.00HK$0.00HK$0.00HK$0.04HK$0.00HK$0.00HK$0.00HK$0.03HK$0.00HK$0.00
2016HK$0.04HK$0.00HK$0.00

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-70.00%-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%December2023FebruaryMarchAprilMay
-66.97%
-12.22%
2186.HK (Luye Pharma Group Ltd)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the Luye Pharma Group Ltd. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Luye Pharma Group Ltd is 81.72%, recorded on Oct 31, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-81.72%Oct 31, 20141970Oct 31, 2022
-6.9%Sep 22, 201411Oct 8, 201415Oct 29, 201426
-5.72%Jul 23, 20146Jul 30, 20144Aug 5, 201410
-3.2%Aug 6, 20142Aug 7, 201411Aug 22, 201413
-2.93%Sep 3, 20142Sep 4, 20143Sep 10, 20145

Volatility Chart

The current Luye Pharma Group Ltd volatility is 8.51%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


5.00%10.00%15.00%December2023FebruaryMarchAprilMay
8.51%
4.15%
2186.HK (Luye Pharma Group Ltd)
Benchmark (^GSPC)